Skip to content
FocusNet Blog

The Zimbabwean Government Rejects ‘Lopsided’ US Health Aid Deal Over Information Fears

Medical funding image
The proposed American financial assistance was intended for initiatives for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has rejected a major American health deal worth 367 million US dollars (272 million pounds) spanning five years because of Washington's demand for confidential data.

This rejection was revealed after a internal memorandum from December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".

An official representative later explained that the US was requesting genetic material for scientific study and commercial gain while refused to guarantee the resulting advantages from future treatments.

"We must now begin the challenging and unfortunate process of winding down our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had furnished over $1.9bn as health assistance to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has urged more talks to reach a deal agreeable to all parties so the nation's vital HIV programme can proceed.

Wider Background

This rejection comes after a comparable case in Kenya, where a court halted a related deal with the US following concerns were raised about the security of citizens' medical information.

After resuming the presidency last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).

The agency had administered assistance for the American government, but Trump stated its spending was "wasteful" and his government was seeking direct bilateral deals to boost transparency and accountability.

According to reports, Sixteen nations in Africa have so far signed similar agreements, constituting more than $18.3bn in new funding.

Details of the Rejected Agreement

This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this partnership could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy via American-funded initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana said the proposed deal was "unfair".

"Our nation was requested to surrender its genetic material and health information over an extended period, with no equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.

"In essence, our country would supply the basic resources for medical research with no assurance that the end products would be available to our population if a new health crisis arise."

National Interest and International Frameworks

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were undermining systems already established through the global health agency.

The spokesperson cited its Pandemic Benefit-Sharing framework designed to deal with potential pandemics.

"This mechanism is designed to ensure that when a country contributes its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the resources to develop them."

These objections over the US deal "should not be misconstrued as anti-American sentiment," he added.

"We are open to continued dialogue with our American counterparts on how subsequent co-operation could be structured in a way that honours the sovereignty and interests of each country."

Medical Community Response

A leading public health body stated it recognised the official position, but recommended that talks should continue given that much of the country's HIV programmes were funded by external financing.

"If specific concerns arise, such as those relating to data governance or implementation frameworks, these can often be addressed via technical clarification and negotiated safeguards," the group added.

The situation underscores the ongoing challenges between accepting much-needed foreign assistance and protecting a country's data in an ever more interconnected world.

PM
By

Pamela Mcneil

A tech strategist with over a decade of experience in digital innovation and business transformation, passionate about simplifying complex tech concepts.

FocusNet Blog

Type to search articles.